Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-03-08
5:02 pm
Sale
13GPrometheus Biosciences, Inc.
RXDX
Cedars Sinai Intellectual Property Co4,001,132
8.42%
-865,000decrease
(-17.78%)
View
2023-02-16
6:07 pm
Sale
13GPrometheus Biosciences, Inc.
RXDX
Cedars Sinai Intellectual Property Co4,866,132
10.5%
-142,376decrease
(-2.84%)
View
2023-02-14
4:27 pm
Purchase
13GPrometheus Biosciences, Inc.
RXDX
Point72 Asset Management L.P.3,114,107
6.7%
1,131,546increase
(+57.07%)
View
2023-02-14
3:01 pm
Sale
13GPrometheus Biosciences, Inc.
RXDX
Cormorant Asset Management LP2,090,000
4.5%
-134,847decrease
(-6.06%)
View
2023-02-14
2:35 pm
Sale
13GPrometheus Biosciences, Inc.
RXDX
PERCEPTIVE ADVISORS LLC1,212,694
2.6%
-1,960,091decrease
(-61.78%)
View
2023-02-14
1:58 pm
Sale
13GPrometheus Biosciences, Inc.
RXDX
EVENTIDE ASSET MANAGEMENT LLC1,032,938
2.2%
-2,709,569decrease
(-72.40%)
View
2023-02-14
10:06 am
Purchase
13GPrometheus Biosciences, Inc.
RXDX
RTW INVESTMENTS LP3,354,303
7.2%
90,272increase
(+2.77%)
View
2023-02-03
12:09 pm
Purchase
13GPrometheus Biosciences, Inc.
RXDX
BlackRock Inc.
BLK
2,807,704
6.1%
918,944increase
(+48.65%)
View
2022-06-06
5:50 pm
Purchase
13GPrometheus Biosciences, Inc.
RXDX
Cormorant Asset Management LP2,224,847
5.68%
376,825increase
(+20.39%)
View
2022-05-09
3:23 pm
Sale
13GPrometheus Biosciences, Inc.
RXDX
BlackRock Inc.
BLK
1,888,760
4.8%
-272,009decrease
(-12.59%)
View
2022-02-14
4:48 pm
Sale
13GPrometheus Biosciences, Inc.
RXDX
PERCEPTIVE ADVISORS LLC3,172,785
8.1%
-141,247decrease
(-4.26%)
View
2022-02-14
4:35 pm
Sale
13GPrometheus Biosciences, Inc.
RXDX
Point72 Asset Management L.P.1,982,561
5.1%
-665,463decrease
(-25.13%)
View
2022-02-14
3:15 pm
Sale
13GPrometheus Biosciences, Inc.
RXDX
Cormorant Asset Management LP1,848,022
4.75%
-250,000decrease
(-11.92%)
View
2022-02-14
11:35 am
Purchase
13GPrometheus Biosciences, Inc.
RXDX
EVENTIDE ASSET MANAGEMENT LLC3,742,507
9.6%
3,742,507increase
(New Position)
View
2022-02-14
10:20 am
Purchase
13GPrometheus Biosciences, Inc.
RXDX
Nestle Health Science US Holdings Inc.3,730,841
9.58%
3,730,841increase
(New Position)
View
2022-02-11
12:47 pm
Purchase
13GPrometheus Biosciences, Inc.
RXDX
Cedars Sinai Intellectual Property Co5,008,508
12.8%
5,008,508increase
(New Position)
View
2022-02-04
4:12 pm
Sale
13GPrometheus Biosciences, Inc.
RXDX
BlackRock Inc.
BLK
2,160,769
5.5%
-1,506,010decrease
(-41.07%)
View
2021-03-26
4:06 pm
Purchase
13GPrometheus Biosciences, Inc.
RXDX
Cormorant Asset Management LP2,098,022
5.41%
2,098,022increase
(New Position)
View
2021-03-22
5:02 pm
Purchase
13GPrometheus Biosciences, Inc.
RXDX
Point72 Asset Management L.P.2,648,024
6.8%
2,648,024increase
(New Position)
View
2021-03-18
09:14 am
Purchase
13GPrometheus Biosciences, Inc.
RXDX
PERCEPTIVE ADVISORS LLC3,314,032
8.6%
3,307,448increase
(+50234.63%)
View
Goto 0, 1, Next